Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shin Nippon Biomedical Laboratories, Ltd. Insider Profile
4 Followers
Shin Nippon Biomedical Laboratories, Ltd., Ten Percent Owner at Satsuma Pharmaceuticals, holds 11.22M shares in Satsuma Pharmaceuticals (Ticker: STSA).
Shin Nippon Biomedical Laboratories, Ltd. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Shin Nippon Biomedical Laboratories, Ltd.'s holdings
Insider Roles
Ten Percent Owner
Roles that Shin Nippon Biomedical Laboratories, Ltd. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd.'s Trading History
List of latest transactions for each holding click on a transaction to see Shin Nippon Biomedical Laboratories, Ltd.'s performance on stock
You May Also Like
Shin Nippon Biomedical Laboratories, Ltd. insider profile FAQ
What is the percentage of profitable transactions made by Shin Nippon Biomedical Laboratories, Ltd.?
The percentage of profitable transactions made by Shin Nippon Biomedical Laboratories, Ltd. is ―.
What is the average return per transaction made by Shin Nippon Biomedical Laboratories, Ltd.?
The average return per transaction made by Shin Nippon Biomedical Laboratories, Ltd. is ―.
What stocks does Shin Nippon Biomedical Laboratories, Ltd. hold?
Shin Nippon Biomedical Laboratories, Ltd. holds: STSA stocks.
What was Shin Nippon Biomedical Laboratories, Ltd.’s latest transaction?
Shin Nippon Biomedical Laboratories, Ltd. latest transaction was an Uninformative Buy of $27.73M.
What was Shin Nippon Biomedical Laboratories, Ltd.'s most profitable transaction?
Shin Nippon Biomedical Laboratories, Ltd.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Shin Nippon Biomedical Laboratories, Ltd.'s role in Satsuma Pharmaceuticals?
Shin Nippon Biomedical Laboratories, Ltd.'s role in Satsuma Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.